News

| Filed under Company News

Company News: BioNTech to Present at Cowen and Company’s 37th Annual Health Care Conference

BioNTech AG, a fully integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that Sean Marett, COO of BioNTech, will be presenting at Cowen and Company’s 37th Annual Health Care Conference that is being held in Boston, MA from March 6 – 8, 2017. The presentation is scheduled for Tuesday, March 7 at 10:00AM Eastern Standard Time.

Read more…

| Filed under Company News

Company News: Standard reference ‘Infections of the musculoskeletal system’ is now available for free as an e-book

– As the publisher, Heraeus Medical is making the 2nd edition of the reference available for download

Heraeus Medical has financed and published the current 2nd edition of the standard reference ‘Infections of the musculoskeletal system’ and is making it available for free in the form of an e-book. Read more…

| Filed under Company News

Company News: Results of Cervical Cancer Study Sponsored by ISA Pharmaceuticals to Be Presented at ASCO-SITC

— First data of phase I/II trial in HPV16-positive patients with late-stage cervical cancer

ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, today announced that results of a company-sponsored clinical Phase I/II trial in late-stage cervical cancer (ISA101-CervISA) will be presented at the inaugural ASCO-SITC congress on immuno-oncology (February 23-25, 2017, Orlando, FL, USA).

Read more…